LOGO
LOGO

Intraday Alerts

Quest Diagnostics Stock Rises 5% On Strong Q1 Results, Raises FY26 Outlook

By RTTNews Staff Writer   ✉   | Published:   | Follow Us On Google News

Shares of Quest Diagnostics Incorporated (DGX) gained nearly 5% on Tuesday after reporting solid first-quarter results.

The stock is currently trading at $205.32, up $9.01 or 4.59%, on the NYSE. It opened at $203.25 after closing the previous session at $196.31. The stock has traded between $164.65 and $213.50 over the past 52 weeks.

Quest Diagnostics reported net income of $252 million, or $2.24 per share, compared with $220 million, or $1.94 per share last year. Revenue increased to $2.89 billion from $2.65 billion.

The company raised its full-year 2026 outlook, now expecting adjusted earnings per share of $10.63 to $10.83 and revenue of $11.78 billion to $11.90 billion.

For comments and feedback contact: editorial@rttnews.com

Business News

Invest in the Best Pharma Stocks by Subscribing to RTT Biotech Investor.
Global Economics Weekly Update: April 13 – April 17, 2026

April 17, 2026 15:29 ET
The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.